Table 2:
12 hr ON: 12 hr OFF (Control) | 24 hr OFF (Light-Deprived) | |||
---|---|---|---|---|
Non-diabetic Vehicle | Diabetic Streptozotocin | Non-diabetic Vehicle | Diabetic Streptozotocin | |
n | 11 | 8 | 12 | 9 |
Body Weight, g, 2 months (Pre-Injection) | 22.4 (1.3) | 19.9 (0.7) | 21.2 (0.8) | 20.7 (0.7) |
Body Weight, g, 4 months (at randomization) | 24.9 (1.4) | 21.4 (0.2)* | 24.1 (0.6) | 21.6 (0.5) |
Body Weight, g, 6 months (at assay) | 25.3 (1.3) | 22.3 (0.3) | 24.8 (0.5) | 22.7 (0.6) |
Random Plasma Glucose, mg/dL, 2 months (Pre-Injection) | 127.0 (3.5) | 149.3 (33.1) | 139.4 (25.9) | 118.5 (10.5) |
Random Glucose (mg/dL), 4 months (at randomization) | 152.2 (10.3) | 550.5 (29.0)**** | 159.0 (6.1) | 521.3 (18.9)**** |
Random Glucose (mg/dL), 6 months (at assay) | 156.9 (15.9) | 525.0 (15.6)**** | 146.4 (13.0) | 545.1 (12.3)**** |
Measures were taken at the time of diabetes induction, at time of randomization to control lighting or light-deprivation, and at the time of assay. Data are represented as mean (SEM) and groups were compared by 1-way (for GTT AUC and Fasting Insulin) or 2-way (for body weight and glucose) ANOVA with Bonferroni post-hoc correction.
= P<0.05
= P<0.0001 compared to healthy controls within same lighting group; P>0.05 for all other comparisons.